Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Muscle & Nerve|July 2, 2026
Clinical Characteristics and Treatment Management of Seronegative Myasthenia Gravis: A Systematic Review of the LiteratureMassimiliano Ugo Verza, Mattia Schiavolin, Francesca Beretta, et al.
Annals of the New York Academy of Sciences|December 22, 2017
Myasthenia gravis with antibodies to MuSK: an updateAmelia Evoli, Paolo E Alboini, Valentina Damato, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 9, 2024
Serological Markers of Clinical Improvement in MuSK Myasthenia GravisGregorio Spagni, Angela Vincent, Bo Sun, et al.
Journal of Neurology|June 25, 2013
Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodiesRaffaele Iorio, Valentina Damato, Massimiliano Mirabella, et al.
Frontiers in Neurology|September 2, 2022
Long-term-video monitoring EEG and 18F-FDG-PET are useful tools to detect residual disease activity in anti-LGI1-Abs encephalitis: A case reportSara Cornacchini, Antonio Farina, Margherita Contento, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 30, 2024
Uveitis: A snapshot in the MOG antibody spectrumClaudia Fabiani, Gian Marco Tosi, Valentina Damato, et al.
Journal of Neurology|March 24, 2026
Half a century of change: demographic trends and their clinical impact in acetylcholine receptor antibody-positive myasthenia gravisSilvia Falso, Gregorio Spagni, Gabriele Monte, et al.
European Journal of Neurology|April 7, 2022
Safety and tolerability of SARS-Cov-2 vaccination in patients with myasthenia gravis: A multicenter experienceAntonio Farina, Silvia Falso, Sara Cornacchini, et al.
Journal of Neuroimmunology|May 23, 2012
Type 1 immune response in progressive multiple sclerosisGiovanni Frisullo, Domenico Plantone, Alessandro Marti, et al.
Pageof 7